Innovation Pipelines That Never Reach Market: The Hidden Graveyard of Corporate R&D Global R&D spending now exceeds $2.5 trillion annually, yet the commercial conversion rate for these investments remains stubbornly low. Between 70% and 90% of innovation projects fail to reach successful commercialization, a statistic that is not a sign of operational failure but a […]
Innovation Pipelines That Never Reach Market Read More »
Creative Thinking as Strategic Infrastructure For decades, creativity was viewed as an intangible luxury — an abstract quality associated with advertising agencies, product designers, or visionary founders. In boardrooms, the language of strategy revolved around efficiency, scale, optimization, capital allocation, and operational discipline. Creativity was often relegated to innovation labs or brainstorming retreats. That worldview
Creative Thinking as Strategic Infrastructure Read More »
Life Sciences Innovation Under Capital Constraints Life sciences innovation has entered a paradoxical phase. Scientific capability is accelerating—driven by breakthroughs in gene editing, mRNA platforms, AI-enabled drug discovery, and precision medicine—yet capital availability has become increasingly selective and volatile. The sector’s structural tension is well captured by a simple fact: developing a single drug now
Life Sciences Innovation Under Capital Constraints Read More »
Innovation Governance That Accelerates Scale In a landscape where technological cycles are compressing, the primary constraint on innovation is no longer creativity—it is governance. The hallmark of high-performing enterprises is not their ability to generate ideas, but their ability to convert those ideas into repeatable, scalable growth. Most organizations fall into the “pilot trap,” where
Innovation Governance That Accelerates Scale Read More »
Innovation Portfolios That Overpromise and Underdeliver Most large companies today do not suffer from a lack of innovation ambition. They suffer from too much of the wrong kind of ambition—poorly balanced, weakly governed, and structurally over-optimistic innovation portfolios. In boardrooms from Frankfurt to San Francisco, “innovation portfolios” have become a fixture of corporate strategy. They
Innovation Portfolios That Overpromise and Underdeliver Read More »
Life Sciences Innovation Under Cost Pressure: Reinventing the Economics of Discovery The life sciences industry has never been more scientifically capable—or more financially constrained. Gene editing, mRNA platforms, and AI-driven drug discovery have expanded what is possible, yet the economics of turning these breakthroughs into medicines are increasingly strained. Understanding this tension is critical for
Life Sciences Innovation Under Cost Pressure Read More »
Innovation Governance: Who Decides What Gets Built? In an era where artificial intelligence systems diagnose diseases, algorithms allocate credit, and platforms shape public discourse, the question of who decides what gets built has become one of the most consequential governance issues of the 21st century. Innovation is no longer simply a matter of engineering or
Innovation Governance- Who Decides What Gets Built Read More »
Innovation Pipelines That Never Deliver Innovation has become a sacred strategic priority. Boards demand it, and CEOs champion it. Yet, despite decades of methodological refinement—from design thinking to agile development—a startling share of corporate innovation pipelines fail to produce meaningful value. Research and real-world evidence suggest a systemic pattern: innovation efforts are prolific, but delivery
Innovation Pipelines That Never Deliver Read More »
Creative Capacity as a Strategic Resource In today’s fast-changing global economy, traditional sources of advantage — scale, capital, standardized processes — are no longer sufficient. What distinguishes the leaders from the laggards in both growth and resilience is something far less tangible but critically strategic: creative capacity. This isn’t artistic flair or marketing pizzazz alone
Creative Capacity as a Strategic Resource Read More »
Innovation Governance That Enables Scale In an age of exponential change—with digital disruption, shifting geopolitics, and capital rotations redefining competitive advantage—innovation has moved from buzzword to compulsory capability. Yet across sectors and geographies, companies and public institutions struggle to convert isolated ideas into scaled breakthrough outcomes. A consistent pattern has emerged: organizations that excel in
Innovation Governance That Enables Scale Read More »
